InMed Pharmaceuticals (INM) Change in Inventory (2022 - 2025)
InMed Pharmaceuticals (INM) reported Change in Inventory of $127091.0 for Q4 2025, up 208.89% on a YoY basis from $41144.7 in Q4 2024, and up 280.61% quarter-over-quarter from -$70366.0 in Q3 2025.
InMed Pharmaceuticals (INM) Change in Inventory (2022 - 2025) Analysis & Trends
InMed Pharmaceuticals has reported Change in Inventory for 4 years, with the latest figure at $127091.0 in Q4 2025.
- For the quarter ending Q4 2025, Change in Inventory rose 208.89% year-over-year to $127091.0; the trailing twelve-month figure through Dec 2025 stood at -$85458.0 (down 121.32% YoY), and the FY2025 full-year result was -$283151.0, down 327.59% from the prior year.
- Change in Inventory for Q4 2025 stood at $127091.0, up from -$70366.0 in the prior quarter.
- The five-year high for Change in Inventory was $1.1 million in Q2 2022, with the low at -$390329.0 in Q3 2023.
- Historically, Change in Inventory has averaged $40239.1 across 4 years, with a median of -$47308.5 in 2024.
- Annual changes were most pronounced in 2024 — Change in Inventory soared 399.09% — and 2025, when it tumbled 190.16%.
- InMed Pharmaceuticals' Change in Inventory stood at -$165017.0 in 2022, then slumped by 31.98% to -$217784.0 in 2023, then soared by 46.41% to -$116717.0 in 2024, then surged by 208.89% to $127091.0 in 2025.
- The last three Change in Inventory figures came in at $127091.0 (Q4 2025), -$70366.0 (Q3 2025), and $147203.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -93.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 114.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 40.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | -4.30 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 6.43 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -2.11 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 20.30 Mn |
| 10 | InMed Pharmaceuticals | 6.00 Mn | 756,271.05 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 127,091.00 |
| Dec 31, 2025 | 127,091.00 |
| Sep 30, 2025 | -70,366.00 |
| Sep 30, 2025 | -70,366.00 |
| Jun 30, 2025 | 147,203.00 |
| Jun 30, 2025 | 147,203.00 |
| Mar 31, 2025 | -289,386.00 |
| Mar 31, 2025 | -289,386.00 |
| Dec 31, 2024 | -116,717.00 |
| Dec 31, 2024 | -116,717.00 |
| Sep 30, 2024 | -24,251.00 |
| Sep 30, 2024 | -24,251.00 |
| Jun 30, 2024 | 92,780.00 |
| Jun 30, 2024 | 92,780.00 |
| Mar 31, 2024 | 449,113.00 |
| Mar 31, 2024 | 449,113.00 |
| Dec 31, 2023 | -217,784.00 |
| Dec 31, 2023 | -217,784.00 |
| Sep 30, 2023 | -390,329.00 |
| Sep 30, 2023 | -390,329.00 |